Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value: $1.56B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 1,545,400 | $152M | 9.7% | $69.32 | +1.7% | COM | 00287Y109 |
| REGN | REGENERON PHARMACEUTICALS | 132,100 | $82.38M | 5.3% | $506.09 | +11.5% | COM | 75886F107 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,104,500 | $80.75M | 5.2% | $54.00 | — | COM | G11196105 |
| BAX | BAXTER INTL INC | 800,900 | $68.96M | 4.4% | $77.66 | 0.0% | COM | 071813109 |
| — | IMMUNOMEDICS INC | 1,911,300 | $67.74M | 4.3% | $30.34 | — | COM | 452907108 |
| EXEL | EXELIXIS INC | 2,694,070 | $63.96M | 4.1% | $21.21 | +9.3% | COM | 30161Q104 |
| — | ALEXION PHARMACEUTICALS INC | 507,700 | $56.98M | 3.7% | $105.16 | — | COM | 015351109 |
| HOLX | HOLOGIC INC | 817,200 | $46.58M | 3.0% | $49.07 | 0.0% | COM | 436440101 |
| — | SEATTLE GENETICS INC | 250,900 | $42.63M | 2.7% | $115.38 | — | COM | 812578102 |
| AUPH | AURINIA PHARMACEUTICALS INC | 2,474,599 | $40.21M | 2.6% | $16.00 | +0.1% | COM | 05156V102 |
| — | MOMENTA PHARMACEUTICALS INC | 1,150,000 | $38.26M | 2.5% | $27.85 | — | COM | 60877T100 |
| — | CHEMOCENTRYX INC | 645,800 | $37.16M | 2.4% | $51.19 | — | COM | 16383L106 |
| ARVN | ARVINAS INC | 1,076,900 | $36.12M | 2.3% | $42.45 | 0.0% | COM | 04335A105 |
| AXSM | AXSOME THERAPEUTICS INC | 404,900 | $33.31M | 2.1% | $79.16 | -2.8% | COM | 05464T104 |
| — | KADMON HLDGS INC | 6,426,700 | $32.91M | 2.1% | $4.75 | — | COM | 48283N106 |
| — | PRINCIPIA BIOPHARMA INC | 548,500 | $32.8M | 2.1% | $59.79 | — | COM | 74257L108 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 674,487 | $32.39M | 2.1% | $38.35 | 0.0% | COM | 98943L107 |
| — | HORIZON THERAPEUTICS PUB LTD | 536,200 | $29.8M | 1.9% | $41.30 | — | SHS | G46188101 |
| ESPR | ESPERION THERAPEUTICS INC NE | 559,700 | $28.72M | 1.8% | $44.03 | -5.0% | COM | 29664W105 |
| AVTR | AVANTOR INC | 1,612,000 | $27.4M | 1.8% | $16.28 | 0.0% | COM | 05352A100 |
| VIR | VIR BIOTECHNOLOGY INC | 620,600 | $25.43M | 1.6% | $33.56 | 0.0% | COM | 92764N102 |
| — | MERSANA THERAPEUTICS INC | 1,069,600 | $25.03M | 1.6% | $23.40 | — | COM | 59045L106 |
| — | DYNAVAX TECHNOLOGIES CORP | 2,674,154 | $23.72M | 1.5% | $3.98 | — | COM NEW | 268158201 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,527,400 | $22.64M | 1.5% | $15.23 | 0.0% | COM | 87164F105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 185,100 | $22.58M | 1.4% | $105.03 | +5.2% | COM | 64125C109 |
| — | SYNEOS HEALTH INC | 366,500 | $21.35M | 1.4% | $58.25 | — | CL A | 87166B102 |
| — | BRISTOL-MYERS SQUIBB CO | 5,786,941 | $20.72M | 1.3% | $3.58 | — | RIGHT 99/99/9999 | 110122157 |
| — | BIOXCEL THERAPEUTICS INC | 388,095 | $20.57M | 1.3% | $36.34 | — | COM | 09075P105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 738,547 | $20.27M | 1.3% | $32.88 | 0.0% | COM | 462260100 |
| CRSP | CRISPR THERAPEUTICS AG | 274,300 | $20.16M | 1.3% | $58.47 | 0.0% | NAMEN AKT | H17182108 |
| — | HARPOON THERAPEUTICS INC | 1,206,351 | $20.02M | 1.3% | $16.60 | — | COM | 41358P106 |
| MCK | MCKESSON CORP | 128,000 | $19.64M | 1.3% | $140.83 | -1.1% | COM | 58155Q103 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,331,100 | $18.91M | 1.2% | $7.88 | 0.0% | COM | 45166A102 |
| CHRS | COHERUS BIOSCIENCES INC | 1,023,500 | $18.28M | 1.2% | $17.50 | -3.3% | COM | 19249H103 |
| EDIT | EDITAS MEDICINE INC | 600,000 | $17.75M | 1.1% | $26.13 | 0.0% | COM | 28106W103 |
| ASND | ASCENDIS PHARMA A S | 118,900 | $17.59M | 1.1% | $139.48 | — | SPONSORED ADR | 04351P101 |
| AZN | ASTRAZENECA PLC | 325,990 | $17.24M | 1.1% | $52.89 | — | SPONSORED ADR | 046353108 |
| ALEC | ALECTOR INC | 686,400 | $16.78M | 1.1% | $25.49 | +8.3% | COM | 014442107 |
| MDT | MEDTRONIC PLC | 173,700 | $15.93M | 1.0% | $81.79 | 0.0% | SHS | G5960L103 |
| — | PREVAIL THERAPEUTICS INC | 1,028,800 | $15.33M | 1.0% | $14.90 | — | COM | 74140Y101 |
| RCUS | ARCUS BIOSCIENCES INC | 589,000 | $14.57M | 0.9% | $26.99 | 0.0% | COM | 03969F109 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 1,438,000 | $14.39M | 0.9% | $10.01 | — | SPONDS ADR | 00653A107 |
| ANIK | ANIKA THERAPEUTICS INC | 362,490 | $13.68M | 0.9% | $36.42 | -9.5% | COM | 035255108 |
| RPRX | ROYALTY PHARMA PLC | 200,000 | $9.71M | 0.6% | $49.50 | 0.0% | SHS CL A | G7709Q104 |
| — | SURFACE ONCOLOGY INC | 1,478,699 | $9.7M | 0.6% | $6.56 | — | COM | 86877M209 |
| — | DECIPHERA PHARMACEUTICALS IN | 156,266 | $9.332M | 0.6% | $59.72 | — | COM | 24344T101 |
| NTLA | INTELLIA THERAPEUTICS INC | 418,178 | $8.79M | 0.6% | $16.99 | 0.0% | COM | 45826J105 |
| — | VERASTEM INC | 4,414,991 | $7.594M | 0.5% | $2.30 | — | COM | 92337C104 |
| — | 1LIFE HEALTHCARE INC | 200,000 | $7.264M | 0.5% | $36.32 | — | COM | 68269G107 |
| — | AKOUOS INC | 315,000 | $7.088M | 0.5% | $22.50 | — | COM | 00973J101 |
| RNAM | AVIDITY BIOSCIENCES INC | 234,814 | $6.636M | 0.4% | $28.83 | 0.0% | COM | 05370A108 |
| — | RETROPHIN INC | 250,000 | $5.103M | 0.3% | $20.41 | — | COM | 761299106 |
| LEGN | LEGEND BIOTECH CORP | 100,000 | $4.256M | 0.3% | $42.56 | — | SPONSORED ADS | 52490G102 |
| — | AVADEL PHARMACEUTICALS PLC | 457,951 | $3.7M | 0.2% | $7.96 | — | SPONSORED ADR | 05337M104 |
| — | FUSION PHARMACEUTICALS INC | 164,554 | $2.875M | 0.2% | $17.47 | — | COM | 36118A100 |
| — | ZOGENIX INC | 97,870 | $2.643M | 0.2% | $27.01 | — | COM NEW | 98978L204 |
| — | PROGENITY INC | 238,680 | $2.148M | 0.1% | $9.00 | — | COM | 74319F107 |